Assignee
KING PHARMACEUTICALS RES & DEV
US·23 granted patents·189 citations·filing 1998–2008
Top patents by PatentIndex Score
23 records- 0193US7714006B1Methods of modifying the bioavailability of metaxaloneKING PHARMACEUTICALS RES & DEV·Filed 2005·Granted May 11, 2010·17 cites·27 claims
- 0289US6358964B1Adenosine, A3 receptor modulatorsKING PHARMACEUTICALS RES & DEV·Filed 2000·Granted Mar 19, 2002·22 cites·18 claims
- 0384US7205403B28-Heteroaryl xanthine adenosine A2B receptor antagonistsKING PHARMACEUTICALS RES & DEV·Filed 2003·Granted Apr 17, 2007·18 cites·32 claims
- 0483US7470698B2Adenosine A3 receptor modulatorsKING PHARMACEUTICALS RES & DEV·Filed 2007·Granted Dec 30, 2008·4 cites·4 claims
- 0582US7271171B2Adenosine A3 receptor modulatorsKING PHARMACEUTICALS RES & DEV·Filed 2005·Granted Sep 18, 2007·4 cites·29 claims
- 0679US6368573B1Diagnostic uses of 2-substituted adenosine carboxamidesKING PHARMACEUTICALS RES & DEV·Filed 1999·Granted Apr 9, 2002·58 cites·12 claims
- 0777US7511133B2Adenosine A3 receptor agonistsKING PHARMACEUTICALS RES & DEV·Filed 2004·Granted Mar 31, 2009·10 cites·1 claims
- 0877US7112607B2Allosteric adenosine receptor modulatorsKING PHARMACEUTICALS RES & DEV·Filed 2002·Granted Sep 26, 2006·7 cites·8 claims
- 0976US7335655B28-heteroaryl xanthine adenosine A2B receptor antagonistsKING PHARMACEUTICALS RES & DEV·Filed 2006·Granted Feb 26, 2008·2 cites·10 claims
- 1076US6248774B1Method for treating hyper-excited sensory nerve functions in humansKING PHARMACEUTICALS RES & DEV·Filed 2000·Granted Jun 19, 2001·8 cites·9 claims
- 1172US7767685B2Adenosine A2B receptor antagonistsKING PHARMACEUTICALS RES & DEV·Filed 2007·Granted Aug 3, 2010·2 cites·7 claims
- 1272US7435740B2Adenosine A3 receptor modulatorsKING PHARMACEUTICALS RES & DEV·Filed 2006·Granted Oct 14, 2008·3 cites·18 claims
- 1370US7094895B2Tyrosyl derivatives and their use as P2X7 receptor modulatorsKING PHARMACEUTICALS RES & DEV·Filed 2002·Granted Aug 22, 2006·4 cites·7 claims
- 1470US6951932B2Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosinesKING PHARMACEUTICALS RES & DEV·Filed 2002·Granted Oct 4, 2005·6 cites·80 claims
- 1568US7101905B2Pharmaceutically active compounds and methods of useKING PHARMACEUTICALS RES & DEV·Filed 2002·Granted Sep 5, 2006·4 cites·8 claims
- 1666US6448253B1Adenosine A3 receptor modulatorsKING PHARMACEUTICALS RES & DEV·Filed 1998·Granted Sep 10, 2002·20 cites·19 claims
- 1758US7723343B2Adenosine A2A receptor antagonistsKING PHARMACEUTICALS RES & DEV·Filed 2008·Granted May 25, 2010·0 cites·14 claims
- 1856US7855209B2Allosteric modulators of the A1 adenosine receptorKING PHARMACEUTICALS RES & DEV·Filed 2007·Granted Dec 21, 2010·0 cites·21 claims
- 1956US7691869B2Pyrrolotriazolopyrimidine derivatives, pharmaceutical compositions containing them and methods of treating conditions and diseases mediated by the adenosine A2A receptor activityKING PHARMACEUTICALS RES & DEV·Filed 2008·Granted Apr 6, 2010·0 cites·17 claims
- 2052US7449490B2Pharmaceutically active compounds and methods of useKING PHARMACEUTICALS RES & DEV·Filed 2006·Granted Nov 11, 2008·0 cites·9 claims
- 2147US7897596B2Allosteric modulators of the A1 adenosine receptorKING PHARMACEUTICALS RES & DEV·Filed 2007·Granted Mar 1, 2011·0 cites·25 claims
- 2246US7691825B2Adenosine A2B receptor agonistsKING PHARMACEUTICALS RES & DEV·Filed 2007·Granted Apr 6, 2010·0 cites·11 claims
- 2339US7342003B2Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogsKING PHARMACEUTICALS RES & DEV·Filed 2005·Granted Mar 11, 2008·0 cites·25 claims
Join the waitlist — get patent alerts
Get an alert when KING PHARMACEUTICALS RES & DEV files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →